Medipattern to Report First Quarter Results Under New IFRS Guidelines
December 01 2011 - 8:00AM
Marketwired
Attention: Business/Financial Editors:
The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a
pioneer in the development of medical imaging software solutions
that help medical practitioners to better understand lesions and
critical anatomy, today announced that its first quarter results
for fiscal 2012 ("Q1 2012") will be completed and filed by December
29, 2011. Q1 2012 is the first reporting period for the Company
under the new International Financial Reporting Standards ("IFRS")
requirements. The TSX and Ontario Securities Commission granted
issuers an additional 30 days to prepare their first interim
financial and operating results under these new guidelines.
Following Q1 2012, the Company will resume its normal course
requirements for interim and annual financial reporting.
About The Medipattern Corporation:
Medipattern® (TSX VENTURE:MKI) is a pioneer in the development
of imaging software solutions that help medical practitioners to
better understand lesions and critical anatomy. Medipattern uses
its Cadenza(TM) technology to process images, finding the salient
region of interest and presenting them in 2D and 3D formats that
enhance the reader's perception. For more information, please visit
the Company's website: www.medipattern.com.
B-CAD® and Medipattern® are a registered trademarks of The
Medipattern Corporation. Visualize:Vascular(TM), Cadenza(TM) and
B-CADmri(TM) are trademarks of The Medipattern Corporation.
Forward-looking statements
This document contains forward-looking statements relating to
Medipattern's performance, operations, or business environment.
These statements are based on what we believe are reasonable
assumptions given currently available information and our
understanding of Medipattern's current activities. We have tried,
whenever possible, to identify these forward-looking statements
using words such as "anticipates,'' "believes,'' "estimates,''
"expects,'' "plans,'' "intends,'' "potential'', and similar
expressions. Forward-looking statements are not guarantees of
future performance and involve risks and uncertainties that are
difficult to predict or control. A number of factors could cause
actual outcomes and results to differ materially from those
expressed in forward-looking statements. These factors include but
are not limited to those set forth in the Company's corporate
filings, (posted at www.sedar.com). In addition, these
forward-looking statements relate to the date on which they are
made. The Company disclaims any intention or obligation to update
or revise any forward-looking statements for any reason. Readers
should not rely on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Contacts: The Medipattern Corporation Jeff Collins CEO (416)
744-0009 ext. 224jcollins@medipattern.com Spinnaker Capital Markets
Inc. Kevin O'Connor (416) 962-3300 x226ko@spinnakercmi.com
The Medipattern Corp. (TSXV:MKI)
Historical Stock Chart
From Jun 2024 to Jul 2024
The Medipattern Corp. (TSXV:MKI)
Historical Stock Chart
From Jul 2023 to Jul 2024